![]() ![]() |
||||||||
|
||||||||
![]() ![]() |
||||||||
![]() |
|
Shiotsu Y, Mori Y, Nishimura M, Hatta T, Imada N, Maki N, Iida K, Iwamoto N, Matsuoka E, Tamagaki K, Kosaki A. Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan. BMC nephrology 2013; 14: 16. Iwasaki Y, Mori K, Ishii K, Maki N, Iijima S, Yoshida T, Okabayashi S, Katakai Y, Lee YJ, Saito A, Fukai H, Kimura N, Ageyama N, Yoshizaki S, Suzuki T, Yasutomi Y, Miyamura T, Kannagi M, Akari H. Long-Term Persistent GBV-B Infection and Development of a Chronic and Progressive Hepatitis C-Like Disease in Marmosets. Front. Microbiol. 2011; 2: 240. Shiotsu Y, Mori Y, Hatta T, Maki N, Iida K, Matsuoka E, Kado H, Ishida R, Kishimoto N, Tamagaki K, Nishimura M, Iwamoto N, Ono T, Matsubara H, Kosaki A. Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease. Nephron extra 2011; 1: 242-250. Shiotsu Y, Mori Y, Nishimura M, Sakoda C, Tokoro T, Hatta T, Maki N, Iida K, Iwamoto N, Ono T, Matsuoka E, Kishimoto N, Tamagaki K, Matsubara H, Kosaki A. Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients. CJASN. 2011; 6: 718-723. Masaki T, Suzuki R, Saeed M, Mori K, Matsuda M, Aizaki H, Ishii K, Maki N, Miyamura T, Matsuura Y, Wakita T, Suzuki T. Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription. J. Virol. 2010; 84: 5824-5835. Matsubara N, Kusano O, Sugamata Y, Itoh T, Mizuii M, Tanaka J, Yoshizawa H. A novel hepatitis B virus surface antigen immunoassay as sensitive as hepatitis B virus nucleic acid testing in detecting early infection. Transfusion 2009; 49: 585-595. Mori Y, Kosaki A, Kishimoto N, Kimura T, Iida K, Fukui M, Nakajima F, Nagahara M, Urakami M, Iwasaka T, Matsubara H. Increased plasma S100A12(EN-RAGE) levels in hemodialysis patients with atherosclerosis. Am. J. Nephrol. 2009; 29(1): 18-24. Tanaka E, Matsumoto A, Yoshizawa K, Maki N. Hepatitis B core-related antigen assay is useful for monitoring the antiviral effect of nucleoside analogue therapy. Intervirology 2008; 51(suppl 1): 3-6. Yokota T, Iijima S, Kubodera T, Ishii K, Katakai Y, Ageyama N, Chen Y, Lee YJ, Unno T, Nishina K, Iwasaki Y, Maki N, Mizusawa H, Akari H. Efficient regulation of viral replication by siRNA in a non-human primate surrogate model for hepatitis C. Biochem. Biophys. Res. Commun. 2007; 361(2): 294-300. Ito T, Maki N, Hazeki O, Sasaki K, Nekooki M. Extracellular and transmembrane region of a podocalyxin-like protein 1 fragment identified from colon cancer cell lines. Cell Biol. Int. 2007; 31: 1518-1524. Matsumoto A, Tanaka E, Minami M, Okanoue T, Yatsuhashi H, Nagaoka S, Suzuki F, Kobayashi M, Chayama K, Imamura M, Yotsuyanagi H, Nakaoka S, Maki N, Kawata S, Kumada H, Iino S, Kiyosawa K. Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy. Hepatology. Res. 2007; 37: 661-666. Ishii K, Iijima S, Kimura N, Lee YJ, Ageyama N, Yagi S, Yamaguchi K, Maki N, Mori K, Yoshizaki S, Machida S, Suzuki T, Iwata N, Sata T, Terao K, Miyamura T, Akari H. GBV-B as a pleiotropic virus: distribution of GBV-B in extrahepatic tissues in vivo. Microbes Infection. 2007; 9: 515-521. Misawa N, Matsumoto A, Tanaka E, Rokuhara A, Yoshizawa K, Umemura T, Maki N, Kimura T, Kiyosawa K. Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics. J. Med. Virol. 2006; 78: 68-73. Rokuhara A, Matsumoto A, Tanaka E, Umemura T, Yoshizawa K, Kimura T, Maki N, Kiyosawa K. Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy. J. Gastroenterol. 2006; 41: 785-790. Yagi S, Mori K, Shiota K. Implication of the HCV subgenome discovery for viral pathogenesis, persistence and proliferation. Future Virol. 2006; 1(4): 425-433. Tanaka E, Matsumoto A, Suzuki F, Kobayashi M, Mizokami M, Tanaka Y, Okanoue T, Minami M, Chayama K, Imamura M, Yatsuhashi H, Nagaoka S, Yotsuyanagi H, Kawata S, Kimura T, Maki N, Iino S, Kiyosawa K and HBV core-related antigen study group. Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance. Liver Int. 2006; 26: 90-96. Yagi S, Mori K, Tanaka E, Matsumoto A, Sunaga F, Kiyosawa K, Yamaguchi K. Identification of novel HCV subgenome replicating persistency in chronic active hepatitis C patients. J. Med. Virol. 2005; 77: 399-413. Iwabata H, Yoshida M, Komatsu Y. Proteomic analysis of organ-specific post-translational lysine-acetylation and -methylation in mice by use of anti-acetyllysine and -methyllysine mouse monoclonal antibodies. Proteomics 2005; 5: 4653-4664. Kimura T, Ohno N, Terada N, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, Ohno S, Maki N. Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domein. J. Bio. Chem. 2005; 280(23): 21713-21719. Rokuhara A, Sun X, Tanaka E, Kimura T, Matsumoto A, Yao D, Yin L, Wang N, Maki N, Kiyosawa K. Hepatitis B virus core and core-related antigen quantification in Chinese patients with chronic genotype B and C hepatitis B virus infection. J. Gastroenterol. Hepatol. 2005; 20: 1726-1730. Kosaki A, Hasegawa T, Kimura T, Iida K, Hitomi J, Matsubara H, Mori Y, Okigaki M, Toyoda N, Masaki H, Inoue-Shibata M, Nishikawa M, Iwasaka T. Increased plasma S100A12(EN-RAGE) levels in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 2004; 89(11): 5423-5428. Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, , Sun X, Yagi S, Maki N, Kiyosawa K. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment. J Viral Hepat. 2003 Jul;10(4):324-30. Kimura T, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, Maki N, New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA J Clin Microbiol. 2003 May;41(5):1901-6. Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N, Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol. 2002 Feb;40(2):439-45. Aoyagi K, Iida K, Ohue C, Matsunaga Y, Tanaka E, Kiyosawa K, Yagi S. Performance of a conventional enzyme immunoassay for hepatitis C virus core antigen in the early phases of hepatitis C infection. Clin Lab. 2001;47(3-4):119-27. Shiokawa D, Tanaka M, Kimura T, Hashizume K, Takasawa R, Ohyama H, Fujita K, Yamada T, Tanuma S. Characterization of two DNase gamma-specific monoclonal antibodies and the in situ detection of DNase gamma in the nuclei of apoptotic rat thymocytes. Biochem Biophys Res Commun. 2000 Aug 28;275(2):343-9. Tanaka E, Ohue C, Aoyagi K, Yamaguchi K, Yagi S, Kiyosawa K, Alter HJ. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology. 2000 Aug;32(2):388-93. Iijima A, Tanaka E, Kobayashi M, Yagi S, Mizokami M, Kiyosawa K. Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum. J Gastroenterol Hepatol. 2000 Mar;15(3):311-9. Aoyagi K, Ohue C, Iida K, Kimura T, Tanaka E, Kiyosawa K, Yagi S. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol. 1999 Jun;37(6):1802-8. Adachi N, Aoyagi K, Saito M, Matsuda I, Yamaguchi K. Age-related changes of serum progastrin-releasing peptide levels during childhood. Acta Paediatrica Japonica 1997;39:336-8 Yagi S, Kashiwakuma T, Yamaguchi K, Chiba Y, Ohtsuka E, Hasegawa A. An epitope chimeric antigen for the hepatitis C virus serological screening test. Biol Pharm Bull. 1996 Oct;19(10):1254-60. Tanaka E, Kiyosawa K, Matsumoto A, Kashiwakuma T, Hasegawa A, Mori H, Yanagihara O, Ohta Y. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa. Hepatology. 1996 Jun;23(6):1330-3. Kashiwakuma T, Hasegawa A, Kajita T, Takata A, Mori H, Ohta Y, Tanaka E, Kiyosawa K, Tanaka T, Tanaka S, Hattori N, Kohara M. Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). J Immunol Methods. 1996 Mar;190(1):79-89. Yamaguchi K, Aoyagi K, Urakami K, Fukutani T, Maki N, Yamamoto S, Otubo K, Miyake Y, Kodama T. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement. Jpn J Cancer Res. 1995 Jul;86:698-705. Aoyagi K, Miyake Y, Urakami K, Kashiwakuma T, Hasegawa A, Kodama T, Yamaguchi K. Enzyme immunoassay of immunoreactive progastrin-releasing peptide(31-98) as tumor marker for small-cell lung carcinoma: development and evaluation. Clin Chem. 1995 Apr;41(4):537-43. Yamaguchi K, Tanaka E, Higashi K, Kiyosawa K, Matsumoto A, Furuta S, Hasegawa A, Tanaka S, Kohara M. Adaptation of Hepatitis C virus for persistent infection in patients with acute hepatitis. Gastroenterology 1994 May;106:1344-8. Tanaka T, Tsukiyama-Kohara K, Yamaguchi K, Yagi S, Tanaka S, Hasegawa A, Ohta Y, Hattori N, Kohara M. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology. 1994 Jun;19(6):1347-53. Tsukiyama-Kohara K, Yamaguchi K, Maki N, Ohta Y, Miki K, Mizokami M, Ohba K, Tanaka S, Hattori N, Nomoto A, et al. Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis. Virology. 1993 Feb;192(2):430-7. Saito M, Hasegawa A, Kashiwakuma T, Kohara M, Sugi M, Miki K, Yamamoto T, Mori H, Ohta Y, Tanaka E, et al. Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7). Clin Chem. 1992 Dec;38(12):2434-9. |
Copyright Advanced Life Science Institute, Inc. All Rights Reserved |